Gynecology Drugs Market is expected to grow with a CAGR of 7.42% by 2026
Growing awareness about women’s health is driving the
growth of Global Gynecology Drugs Market in the forecast period.
According to TechSci Research report, “Global Gynecology
Drugs Market
By Therapeutics (Hormonal Therapy vs. Non-Hormonal Therapy), By Indication (Gynecology Cancers, Polycystic Ovary Syndrome,
Contraception, Endometriosis, Female Infertility, Gynecology Infections, Postmenopausal
Disorders), By Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, Online Pharmacies), By Region, Competition Forecast &
Opportunities, 2026”, the global gynecology
drugs market is projected to grow at a CAGR of 7.42% and will reach USD20222.86
million by 2026 owing to rising incidences of gynecological diseases, change in
lifestyle of the global female population, and rise in the demand for better
gynecological treatments. Moreover, the increasing instances of chronic
diseases like cancer is driving the growth of the global gynecology market in
the next five years. However, stringent regulations and high-quality standards
set by market leaders are projected to restrain the penetration of new
entrants, which will eventually hinder the market growth.
Gynecology drugs are the therapeutic drugs that are conditioned for the
treatments of gynecologic diseases. Gynecological disease is a medical
condition affecting the female reproductive system. Gynecological diseases
include cervical dysplasia, menstrual disorders, pelvic floor prolapse, pelvic
pain, polycystic ovarian syndrome, uterine fibroids, urinary incontinence.
Gynecology disorders may cause severe issues in case of pregnant women.
According to the World Health Organization, in 2020, between 2018 and
2030, the annual incidence rate of cervical cancer cases is predicted to rise
from 570 000 to 700 000. The number of deaths each year is expected to climb
from 311 000 to 400 000. It is roughly twice as common in low- and
middle-income nations, with death rates three times higher than in high-income
nations.
Browse over 108
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Gynecology Drugs Market"
https://www.techsciresearch.com/report/gynecology-drugs-market/7427.html
The global gynecology drugs market is segmented by
therapeutics, indication, distribution channel, regional distribution, and
competitive landscape. Based on indication, the market is further fragmented
into gynecology cancers, polycystic ovary syndrome, contraception,
endometriosis, female infertility, gynecology infections, postmenopausal
disorders. Amongst these, the Polycystic ovary syndrome segment is expected to
lead the market in the forecast period.
Gynecology cancers are the type of cancers that are
formed in the reproductive organs. Cases of cervical cancers, ovarian cancer,
uterine cancer, vaginal cancer, vulvar cancer are all types of gynecology
cancers that are prevailing in the last five years. Endometriosis is a disorder
in which uterus tissues grow outside the uterus lining. These tissues outgrow
over ovaries, fallopian tubes or the intestines. Female infertility is about
the condition, where women lose the ability to procreate. In this procedure,
the ovulation and menstrual cycles are irregular which means that the woman is
not producing the ovarian eggs for the fertilization. Reproductive organ
failure may lead to female infertility too. Menopausal disorder is the medical
condition in which the female patient is affected by gynecological disorder after
they experience their menopause.
Major companies in the market are Amgen Inc., F.
Hoffmann-La Roche Ltd., Novartis Ltd., Bayer AG, Merck & Co., Inc., GlaxoSmithKline
Plc, Sanofi SA, Eli Lilly and Company Ltd., Ferring Pharmaceuticals A/S, AstraZeneca
Plc, TherapeuticsMD, Inc., AbbVie Inc., Abbott Laboratories Ltd., Lupin
Pharmaceuticals, Inc., Pfizer Inc., among others. The market players are
actively involved in the technological advancements of the therapeutics as well
as research and development of the medical devices used for the administration
of gynecology drugs. Other strategies include partnerships among the market
players.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7427
Customers can also request for
10% free customization on this report.
“North America is a
promising region for the future market owing to the excellent healthcare
industry developments. Moreover, the US Food and Drug Administration (FDA)
approval towards various therapeutics is driving the growth of the market
consistently. Also, United States is the major economy that suffers due to the
rising incidences of breast cancer, menopausal disorders, polycystic ovary
syndrome and other chronical diseases related to women. Furthermore, working
class women are a large population of the country, and the work environment is
often stressful which causes severe issues in the gynae health. Also, issues
like polycystic ovarian disorder are also rapidly increasing in the Asia
Pacific region, thus the market is anticipated to grow at a significant share
in the forecast period,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based Global management consulting firm.
“Global Gynecology Drugs
Market By Therapeutics (Hormonal Therapy vs. Non-Hormonal Therapy), By
Indication (Gynecology Cancers, Polycystic Ovary Syndrome, Contraception,
Endometriosis, Female Infertility, Gynecology Infections, Postmenopausal
Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies,
Online Pharmacies), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future
growth potential of global gynecology drugs market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global gynecology drugs market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/